The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Risk factors in the development of stem cell therapy
Open accessAbstract
Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of damaged tissues for which there are currently no or limited therapeutic options. The potential of stem cell therapies has long been recognised and the creation of induced pluripotent stem cells (iPSC) has boosted the stem cell field leading to increasing development and scientific knowledge. Despite the clinical potential of stem cell based medicinal products there are also potential and unanticipated risks. These risks deserve a thorough discussion within the perspective of current scientific knowledge and experience. Evaluation of potential risks should be a prerequisite step before clinical use of stem cell based medicinal products.The risk profile of stem cell based medicinal products depends on many risk factors, which include the type of stem cells, their differentiation status and proliferation capacity, the route of administration, the intended location, in vitro culture and/or other manipulation steps, irreversibility of treatment, need/possibility for concurrent tissue regeneration in case of irreversible tissue loss, and long-term survival of engrafted cells. Together these factors determine the risk profile associated with a stem cell based medicinal product. The identified risks (i.e. risks identified in clinical experience) or potential/theoretical risks (i.e. risks observed in animal studies) include tumour formation, unwanted immune responses and the transmission of adventitious agents.Currently, there is no clinical experience with pluripotent stem cells (i.e. embryonal stem cells and iPSC). Based on their characteristics of unlimited self-renewal and high proliferation rate the risks associated with a product containing these cells (e.g. risk on tumour formation) are considered high, if not perceived to be unacceptable. In contrast, the vast majority of small-sized clinical trials conducted with mesenchymal stem/stromal cells (MSC) in regenerative medicine applications has not reported major health concerns, suggesting that MSC therapies could be relatively safe. However, in some clinical trials serious adverse events have been reported, which emphasizes the need for additional knowledge, particularly with regard to biological mechanisms and long term safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcia-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,036
RetractedRetraction: Spontaneous Human Adult Stem Cell Transformation
de la Fuente, R., Bernad, A., Garcı́a-Castro, J., Martin, M. C., & Cigudosa, J. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2451 · Cited by 109
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“The transformation of an adult somatic cell into a pluripotent stem cell (iPSC) was firstly achieved by inducing a “forced” expression of specific genes [8-14].”
BackgroundEstablishment in culture of pluripotential cells from mouse embryos
Evans, M. J., & Kaufman, M. H. (1981) · Nature · doi:10.1038/292154a0 · Cited by 8,607
Martin, G. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7634 · Cited by 5,746
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Isolation of amniotic stem cell lines with potential for therapy
De Coppi, P., Bartsch, G., Siddiqui, M. M., Xu, T., Santos, C. C., Perin, L., Mostoslavsky, G., Serre, A. C., Snyder, E. Y., Yoo, J. J., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1274 · Cited by 1,869
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Primary Bioassay of Human Tumor Stem Cells
Hamburger, A. W., & Salmon, S. E. (1977) · Science · doi:10.1126/science.560061 · Cited by 1,643
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines
Bradley, A., Evans, M., Kaufman, M. H., & Robertson, E. (1984) · Nature · doi:10.1038/309255a0 · Cited by 1,525
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423 · cited 1×
“The transformation of an adult somatic cell into a pluripotent stem cell (iPSC) was firstly achieved by inducing a “forced” expression of specific genes [8-14].”
BackgroundInduction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,341
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009) · Nature · doi:10.1038/nature07864 · Cited by 1,251
Gastric Cancer Originating from Bone Marrow-Derived Cells
Houghton, J., Stoicov, C., Nomura, S., Rogers, A. B., Carlson, J., Li, H., Cai, X., Fox, J. G., Goldenring, J. R., & Wang, T. C. (2004) · Science · doi:10.1126/science.1099513 · Cited by 1,170
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166 · cited 4×
“The secretion of various soluble factors by MSC [84] may enhance this effect.”
BackgroundInfluentialMicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,124
Amariglio, N., Hirshberg, A., Scheithauer, B. W., Cohen, Y., Loewenthal, R., Trakhtenbrot, L., Paz, N., Koren-Michowitz, M., Waldman, D., Leider-Trejo, L., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000029 · Cited by 933
Human embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Bernardo, M. E., Zaffaroni, N., Novara, F., Cometa, A. M., Avanzini, M. A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4690 · Cited by 694
A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
Shi, Y., Tae Do, J., Desponts, C., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.011 · Cited by 671
Yamanaka, S. (2009) · Cell · doi:10.1016/j.cell.2009.03.034 · Cited by 659 · cited 2×
“Furthermore it has been suggested that sustained expression of the reprogramming transgenes might suppress differentiation of iPSCs which may result in an increased tendency to teratoma formation when these cells are transplanted into patients [76].”
BackgroundKoç, O., Day, J., Nieder, M., Gerson, S., Lazarus, H., & Krivit, W. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703650 · Cited by 652
Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A. I., Ware, C. B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., & Murry, C. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6769com · Cited by 646
Røsland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J.-C., Goldbrunner, R., Lønning, P. E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4630 · Cited by 644
Potential risks of bone marrow cell transplantation into infarcted hearts
Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., Fries, J. W. U., Tiemann, K., Bohlen, H., Hescheler, J., et al. (2007) · Blood · doi:10.1182/blood-2006-12-063412 · Cited by 623
Giordano, A., Galderisi, U., & Marino, I. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20959 · Cited by 609
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
Horwitz, E. M., Prockop, D. J., Gordon, P. L., Koo, W. W. K., Fitzpatrick, L. A., Neel, M. D., McCarville, M. E., Orchard, P. J., Pyeritz, R. E., & Brenner, M. K. (2001) · Blood · doi:10.1182/blood.v97.5.1227 · Cited by 571
Adult neurogenesis and neural stem cells of the central nervous system in mammals
Taupin, P., & Gage, F. H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10378 · Cited by 527
Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys
Karahuseyinoglu, S., Cinar, O., Kilic, E., Kara, F., Akay, G. G., Demiralp, D. Ö., Tukun, A., Uckan, D., & Can, A. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0286 · Cited by 515
Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
Knoepfler, P. S. (2009) · Stem Cells · doi:10.1002/stem.37 · Cited by 456
Tarte, K., Gaillard, J., Lataillade, J.-J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., et al. (2010) · Blood · doi:10.1182/blood-2009-05-219907 · Cited by 430 · cited 5×
“At the moment, human MSC appear to be less prone to malignant transformation during in vitro culture when compared to murine MSC [61,69], but further studies are urgently needed.”
BackgroundInfluentialNing, H., Yang, F., Jiang, M., Hu, L., Feng, K., Zhang, J., Yu, Z., Li, B., Xu, C., Li, Y., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405090 · Cited by 407
Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0188 · Cited by 402 · cited 1×
“Both ESC-derived cells [87-89] and especially MSCs [81,90,91] have been reported to be immune-privileged and have a low immunogenic potential.”
BackgroundA Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo
BRUCE, W. R., & VAN DER GAAG, H. (1963) · Nature · doi:10.1038/199079a0 · Cited by 398
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?
Prusa, A.-R. (2003) · Human Reproduction · doi:10.1093/humrep/deg279 · Cited by 379
A Drug-Inducible System for Direct Reprogramming of Human Somatic Cells to Pluripotency
Hockemeyer, D., Soldner, F., Cook, E. G., Gao, Q., Mitalipova, M., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.014 · Cited by 367
Human Embryonic Stem Cells Possess Immune‐Privileged Properties
Li, L., Baroja, M. L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J., et al. (2004) · STEM CELLS · doi:10.1634/stemcells.22-4-448 · Cited by 360
Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke
Erdö, F., Bührle, C., Blunk, J., Hoehn, M., Xia, Y., Fleischmann, B., Föcking, M., Küstermann, E., Kolossov, E., Hescheler, J., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071886.63724.fb · Cited by 355
Yu, J., & Thomson, J. A. (2008) · Genes & Development · doi:10.1101/gad.1689808 · Cited by 342
HLA-haplotype banking and iPS cells
Nakatsuji, N., Nakajima, F., & Tokunaga, K. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-739 · Cited by 336
From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research
Solter, D. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1827 · Cited by 326
Rhodes, K. E., Gekas, C., Wang, Y., Lux, C. T., Francis, C. S., Chan, D. N., Conway, S., Orkin, S. H., Yoder, M. C., & Mikkola, H. K. A. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.001 · Cited by 325
Torsvik, A., Røsland, G. V., Svendsen, A., Molven, A., Immervoll, H., McCormack, E., Lønning, P. E., Primon, M., Sobala, E., Tonn, J.-C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1305 · Cited by 284
Characterization of human embryonic stem cells with features of neoplastic progression
Werbowetski-Ogilvie, T. E., Bossé, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A., Wynder, T., Smith, M.-J., Dingwall, S., Carter, T., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1516 · Cited by 278
Prokhorova, T. A., Harkness, L. M., Frandsen, U., Ditzel, N., Schrøder, H. D., Burns, J. S., & Kassem, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2007.0266 · Cited by 277
Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz-Eldor, J., Rasool, O., Dvorak, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 277
Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
Lazennec, G., & Jorgensen, C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1006 · Cited by 255
Novel Sources of Fetal Stem Cells: Where do they Fit on the Developmental Continuum?
Pappa, K. I., & Anagnou, N. P. (2009) · Regenerative Medicine · doi:10.2217/rme.09.12 · Cited by 217
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors
Barozzi, P., Luppi, M., Facchetti, F., Mecucci, C., Alù, M., Sarid, R., Rasini, V., Ravazzini, L., Rossi, E., Festa, S., et al. (2003) · Nature Medicine · doi:10.1038/nm862 · Cited by 215
Prockop, D. J., & Olson, S. D. (2007) · Blood · doi:10.1182/blood-2006-03-013433 · Cited by 202
Li, H., Fan, X., Kovi, R. C., Jo, Y., Moquin, B., Konz, R., Stoicov, C., Kurt-Jones, E., Grossman, S. R., Lyle, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2665 · Cited by 194
Carlsson, T., Carta, M., Winkler, C., Björklund, A., & Kirik, D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2079-07.2007 · Cited by 191
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells
García, S., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Garcı́a-Castro, J., & Bernad, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.016 · Cited by 158
Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G. T., & Kassem, M. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.004 · Cited by 155
Mesenchymal Stromal Cells from Umbilical Cord Blood
Bieback, K., & Klüter, H. (2007) · Current Stem Cell Research & Therapy · doi:10.2174/157488807782793763 · Cited by 153
Tugwell, B. D., Patel, P. R., Williams, I. T., Hedberg, K., Chai, F., Nainan, O. V., Thomas, A. R., Woll, J. E., Bell, B. P., & Cieslak, P. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00008 · Cited by 140
Retroviral integration and human gene therapy
Bushman, F. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32949 · Cited by 138 · cited 1×
“The use of retroviruses and lentiviruses raises safety issues similar to those that have been observed in the gene therapy of patients with X-linked severe combined immunodeficiency for which the occurrence of cancer has been reported due to integration of therapeutic vectors activating oncogenes [70,71].”
BackgroundImmunomodulatory Effect of Mesenchymal Stromal Cells: Possible Mechanisms
Nasef, A., Ashammakhi, N. A., & Fouillard, L. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.4.531 · Cited by 136
Stem Cell Therapy for Heart Failure
Menasché, P. (2009) · Circulation · doi:10.1161/circulationaha.108.812693 · Cited by 121
Shih, C.-C., Forman, S. J., Chu, P. G., & Slovak, M. L. (2007) · Stem Cells and Development · doi:10.1089/scd.2007.0070 · Cited by 115
Sundin, M., Örvell, C., Rasmusson, I., Sundberg, B., Ringdén, O. T. H., & Blanc, K. L. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705368 · Cited by 114
Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling
Koch, P., Kokaia, Z., Lindvall, O., & Brüstle, O. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70202-9 · Cited by 110
Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers
Li, H., Stoicov, C., Rogers, A. B., & Houghton, J. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.363 · Cited by 108
Loss of p53 Induces Tumorigenesis in p21-Deficient Mesenchymal Stem Cells
Rodrı́guez, R., Rubio, R., Masip, M., Catalina, P., Nieto, A., de la Cueva, T., Arriero, M., Martín, N. S., de la Cueva, E., Balomenos, D., et al. (2009) · Neoplasia · doi:10.1593/neo.81620 · Cited by 106
Endothelial progenitor cells – hype or hope?
Pearson, J. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03214.x · Cited by 106
iPS cell technology in regenerative medicine
Lengner, C. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05213.x · Cited by 105
Skin Carcinoma Arising From Donor Cells in a Kidney Transplant Recipient
Aractingi, S., Kanitakis, J., Euvrard, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2783 · Cited by 93
The key role of adult stem cells: therapeutic perspectives
Pessina, A., & Gribaldo, L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148517 · Cited by 88
Adès, L., Guardiola, P., & Socié, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0010 · Cited by 79
Miura, Y., Gao, Z., Miura, M., Seo, B., Sonoyama, W., Chen, W., Gronthos, S., Zhang, L., & Shi, S. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0089 · Cited by 77
Emerging hurdles in stem cell therapy for peripheral vascular disease
Aranguren, X. L., Verfaillie, C. M., & Luttun, A. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0394-3 · Cited by 72
Regenerative Therapy in Peripheral Artery Disease
Germani, A., Campli, C. D., Pompilio, G., Biglioli, P., & Capogrossi, M. C. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2009.00105.x · Cited by 46
Embryonic stem cell lines derived from human blastocysts (vol 282, pg 1147, 1998)
Pringle, H. (1998) · Science · Cited by 45
Spontaneous In Vitro Transformation of Adult Neural Precursors into Stem‐Like Cancer Cells
Siebzehnrübl, F. A., Jeske, I., Müller, D., Buslei, R., Coras, R., Hahnen, E., Huttner, H. B., Corbeil, D., Kaesbauer, J., Appl, T., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00189.x · Cited by 42
To Scientists' Dismay, Mixed-Up Cell Lines Strike Again
Vogel, G. (2010) · Science · doi:10.1126/science.329.5995.1004 · Cited by 39
Mouse induced pluripotent stem cells
Geoghegan, E., & Byrnes, L. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082640eg · Cited by 36
Mohib, K., Allan, D., & Wang, L. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9185-7 · Cited by 35
Lasala, G. P., & Minguell, J. J. (2008) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.09.007 · Cited by 32
Stem cells and nuclear reprogramming
Šarić, T., & Hescheler, J. (2008) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645700801969303 · Cited by 15
Kassem, M. S., & Burns, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1541 · Cited by 8
Induced pluripotent stem cell (iPS) technology: promises and challenges
Esteban, M. A., Gan, Y., Qin, D., & Pei, D. (2009) · Chinese Science Bulletin · doi:10.1007/s11434-009-0014-9 · Cited by 5
Cited by
Tao, S.-C., Yuan, T., Zhang, Y.-L., Yin, W.-J., Guo, S.-C., & Zhang, C.-Q. (2017) · Theranostics · doi:10.7150/thno.17133 · Cited by 729
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Hu, Y., Rao, S.-S., Wang, Z.-X., Cao, J., Tan, Y.-J., Luo, J., Li, H.-M., Zhang, W.-S., Chen, C.-Y., & Xie, H. (2018) · Theranostics · doi:10.7150/thno.21234 · Cited by 574
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
Musiał-Wysocka, A., Kot, M., & Majka, M. (2019) · Cell Transplantation · doi:10.1177/0963689719837897 · Cited by 534
Exosomes — beyond stem cells for restorative therapy in stroke and neurological injury
Zhang, Z. G., Buller, B., & Chopp, M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0126-4 · Cited by 503
Metadata
- Authors
- Herberts, C. A., Kwa, M. S., & Hermsen, H. P.
- Venue
- Journal of Translational Medicine
- Published
- 2011-03-22
- Volume
- 9
- Issue
- 1
- Pages
- 29-29
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2164384962
- Cited by
- 753
- References
- 94
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.